Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
Status:
Recruiting
Trial end date:
2023-08-17
Target enrollment:
Participant gender:
Summary
The primary objectives of this study are to explore the therapeutic effect of eluxadoline in
treating irritable bowel syndrome with diarrhea (IBS-D) in pediatric participants 6-17 years
of age, to evaluate the pharmacokinetics of eluxadoline in pediatric participants with IBS-D,
and to evaluate the safety and tolerability of eluxadoline in pediatric participants with
IBS-D.